<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="chapter-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">978-981-15-4099-8</journal-id>
<journal-id journal-id-type="doi">10.1007/978-981-15-4099-8</journal-id>
<journal-id journal-id-type="nlm-ta">Microbial Diversity, Interventions and Scope</journal-id>
<journal-title-group>
<journal-title>Microbial Diversity, Interventions and Scope</journal-title>
</journal-title-group>
<isbn publication-format="print">978-981-15-4098-1</isbn>
<isbn publication-format="electronic">978-981-15-4099-8</isbn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmc">7315774</article-id>
<article-id pub-id-type="publisher-id">20</article-id>
<article-id pub-id-type="doi">10.1007/978-981-15-4099-8_20</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of Human Microbiome on Health</article-title>
</title-group>
<contrib-group content-type="book editors">
<contrib contrib-type="editor">
<name>
<surname>Sharma</surname>
<given-names>Shiwani Guleria</given-names>
</name>
<address>
<email>shg1988@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Sharma</surname>
<given-names>Neeta Raj</given-names>
</name>
<address>
<email>neeta.raj@lpu.co.in</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Sharma</surname>
<given-names>Mohit</given-names>
</name>
<address>
<email>mrsharma236@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.449005.c</institution-id><institution>School of Bioengineering and Biosciences, </institution><institution>Lovely Professional Univeristy, </institution></institution-wrap>Phagwara, Punjab India </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.449005.c</institution-id><institution>School of Bioengineering and Biosciences, </institution><institution>Lovely Professional Univeristy, </institution></institution-wrap>Phagwara, Punjab India </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.413495.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1767 3121</institution-id><institution>Molecular Genetics Laboratory, </institution><institution>Dayanand Medical College and Hospital, </institution></institution-wrap>Ludhiana, Punjab India </aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Das</surname>
<given-names>Sujata</given-names>
</name>
<address>
<email>sujata.nss@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khanna</surname>
<given-names>Charu</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Shalini</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nandi</surname>
<given-names>Shilpa</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verma</surname>
<given-names>Reema</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.449005.c</institution-id><institution>School of Bioengineering and Biosciences, </institution><institution>Lovely Professional University, </institution></institution-wrap>Phagwara, Punjab India </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.449005.c</institution-id><institution>School of Pharmaceutical Sciences, </institution><institution>Lovely Professional University, </institution></institution-wrap>Phagwara, Punjab India </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>10</day>
<month>3</month>
<year>2020</year>
</pub-date>
<fpage>349</fpage>
<lpage>373</lpage>
<permissions>
<copyright-statement>© Springer Nature Singapore Pte Ltd. 2020</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The human genome in the recent years, by the advent of technological advancements, has emerged as a major prolocutor for reciprocity between the human body and the food consumed. As known, microbiome comprises all the genetic materials within a microbiota and can thereby be also referred to as metagenome of the microbiota. Contemporary researches have revealed the influence of microbiome not only on human mind and health status, but also in wide range of disease switching, ranging from cardio-metabolic diseases, allergies and obesities to life-threatening diseases such as cancer. Though the complete mechanism of many diseases is yet unclear, research works have revealed that the metabolites, nutrients and microbes can be regarded as the key players for such physiological state. The major approach of this chapter is to enlighten the interrelationship of the microbiome on the human health either in a synergistic or in an antagonistic manner.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Genome</kwd>
<kwd>Microbiome</kwd>
<kwd>Microbiota</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Nature Singapore Pte Ltd. 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">In the last few decades, immense initiatives have been taken in understanding the role of microbiome on human health. In the present day, either in the field of therapeutic development or medical treatment, the impact of microbiome is especially apparent in the studies of different microbial communities and the human microbiome. In the recent times, ‘omics’ has provided a significant impetus on all the facets of biological research which has ushered the field to gain in momentum. The study, which is contemporarily popularised as study of ‘human microbiome’, is an outcome of the advancement in the field of genomics and other fields of microbiology, which has given the classical microbiology a new outlook and perspective. Thereby, the attention was driven and directed towards the genomics, which was the major objective of the Human Microbiome Project (HMP) (Turnbough and Wilson <xref ref-type="bibr" rid="CR100">2007</xref>). The HMP was used for the characterisation of all the microbial communities living in the human body, eventually switching the interest towards, not only, the type of microbes existing in the human body but also to the role and activity they perform both in the case of a healthy and diseased individual. Since 2003, after the publication of the first human genome (Chial <xref ref-type="bibr" rid="CR17">2008</xref>), the biomedical research on microbiome has obtained a significant scientific attention. There has been an immense leap from the culture-based surveys of various tissues or organs, for example, of gut and oral cavity, to molecular profiling of the microbial communities and their biochemical products like enzymes, proteins, and amino acids in all the different ecological niches of the human body (Eckburg et al. <xref ref-type="bibr" rid="CR27">2005</xref>; Gill et al. <xref ref-type="bibr" rid="CR36">2006</xref>; Costello et al. <xref ref-type="bibr" rid="CR21">2009</xref>) for this subject. This chapter attempts to put an insight into the distribution and diversification of human microbiome, the behaviour of human microbiome on the human health and microbiome as a paradigm for the future nutritional and medicinal strategies for human benefits.</p>
</sec>
<sec id="Sec2">
<title>Systemic Microbiome: Its Distribution and Diversification</title>
<p id="Par3">Over 100 trillion microbes are estimated to be residing both inside and over the surface of humans, possessing genome which is approximately 150 times to that of the entire human being (Wang et al. <xref ref-type="bibr" rid="CR106">2017</xref>). This includes microbes of different families such as bacteria, fungi, archaea and viruses, contributing about eight million unique protein-coding genes as compared to the human genome, which comprises only around 22,000 protein-coding genes (Tomayko et al. <xref ref-type="bibr" rid="CR99">2013</xref>). This variation and the nature of the organism, specific to the specific anatomic site of the body, is a consequence of their specific growth requirement. The other determinants for such growth include coevolution of microorganism, their extensive interaction amongst each other and with the human host, variation in the composition and function with respect to the population, human life span and inconsistency of the body sites, ecologic condition, difference in the oxygen tension, airway luminal temperature, mechanism of muco-ciliary clearance, sex, genetics and socio-economic status. Hence, there has been a development of the concept of interdependence, in variety of physiologic, immunologic and metabolic processes, which ultimately determines the microbiome community in a particular site of the human body system.</p>
<sec id="Sec3">
<title>The Gut Microbiome</title>
<p id="Par4">Amongst all the human systemic microbiome, the gut microbiome, composed of the genetic material of the microorganisms in the gut, occupies a very essential and special position. They play an important role in various physiological processes like metabolism, immunity development and nourishment supply. The genotype and the immune system of the host have been shown to contribute towards the development of gut microbiota (Thaiss et al. <xref ref-type="bibr" rid="CR97">2016</xref>). In response to environmental factors, such as diet, pathogens and xenobiotic substances, a crosstalk occurs between the human immune system and the microbiome. For instance, the myeloid cells, epithelial layer and the innate lymphoid cells, part of the immune system, crosstalks with the gut microbiota for which the microbiome composition, host physiology and disease susceptibility are the main consequences of such crosstalks and feedback loops between them. Along with the bacterial community, like Firmicutes and Bacteroidetes species (Table <xref ref-type="table" rid="Tab1">20.1</xref>), these interactions are also contributed by the other microbiota like fungi (Pothoulakis <xref ref-type="bibr" rid="CR80">2009</xref>), archaea and viruses (Breitbart et al. <xref ref-type="bibr" rid="CR8">2003</xref>). Though the understanding of the immunological relationship between the fungi and archaea is limited currently, the trans-kingdom commensalism is expected to be formed from infancy (LaTuga et al. <xref ref-type="bibr" rid="CR54">2011</xref>).<table-wrap id="Tab1"><label>Table 20.1</label><caption><p>Distribution and diversity of human microbiome</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Site</th><th>Name of dominant species</th><th>Average genome size</th><th>References</th></tr></thead><tbody><tr><td>Oral</td><td><italic>Streptococcus, Haemophilus, Actinomyces, Prevotella</italic></td><td>2.11 Mb</td><td>Nayfach and Pollard (<xref ref-type="bibr" rid="CR69">2015</xref>) and Gao et al. (<xref ref-type="bibr" rid="CR32">2018</xref>)</td></tr><tr><td>Gut</td><td><italic>Firmicutes, Bacteroidetes, Bacteroides, Streptococcus, Ruminococcus, Enterococcus, Bifidobacterium, Clostridium, Enterococcus, Lactobacillus</italic> and <italic>Clostridium</italic></td><td>2.5–5.8 Mb</td><td>Nayfach and Pollard (<xref ref-type="bibr" rid="CR69">2015</xref>), Bull and Plummer (<xref ref-type="bibr" rid="CR9">2014</xref>), and Bäckhed et al. (<xref ref-type="bibr" rid="CR3">2012</xref>)</td></tr><tr><td>Skin</td><td><italic>Firmicutes, Proteobacteria, Bacteroides, Actinobacteria, Corynebacterium</italic> spp<italic>., Staphylococcus</italic> spp<italic>., Propionibacteriun</italic> spp<italic>., Malassezia</italic> spp<italic>., Cryptococcus</italic> spp<italic>., Epiciccum</italic> spp<italic>., Aspergillus</italic> spp<italic>.,</italic> and <italic>Rhodotorula</italic> spp. Gram negative organism abundance</td><td rowspan="3">2.23 Mb</td><td>Grice and Segre (<xref ref-type="bibr" rid="CR37">2011</xref>), Ross et al. (<xref ref-type="bibr" rid="CR83">2017</xref>), and Byrd et al. (<xref ref-type="bibr" rid="CR11">2018</xref>)</td></tr><tr><td rowspan="2">Respiratory system</td><td><bold>URT:</bold>
<italic>Staphylococcus</italic> spp<italic>., Corynebacterium</italic> spp<italic>., Propionibacterium</italic> spp<italic>., Moraxella</italic> spp<italic>., Streptococcus</italic> spp. and <italic>Dolosigranulum</italic> spp. <italic>Haemophilus</italic> spp<italic>., Rothia</italic> spp<italic>., Neisseria</italic> spp<italic>., Streptococcal</italic> spp., <italic>Veillonella</italic> spp<italic>., Leptotrichia</italic> spp<italic>., Prevotella</italic> spp., <italic>Penicillium</italic> spp<italic>., Candida</italic> spp<italic>., Aspergillus</italic> spp<italic>.,</italic> and <italic>Alternaria</italic> spp<italic>.,</italic> human bocavirus, human adenovirus, human rhinovirus, human coronavirus, polyoma viruses and other <italic>Anelloviridae</italic> family</td><td rowspan="2">Nayfach and Pollard (<xref ref-type="bibr" rid="CR69">2015</xref>), Man et al. (<xref ref-type="bibr" rid="CR61">2017</xref>), Faner et al. (<xref ref-type="bibr" rid="CR30">2017</xref>), Moffatt and Cookson (<xref ref-type="bibr" rid="CR66">2017</xref>), Dickson et al. (<xref ref-type="bibr" rid="CR26">2016</xref>), and Yatera et al. (<xref ref-type="bibr" rid="CR108">2018</xref>)</td></tr><tr><td><bold>LRT:</bold>
<italic>Acinetobacter</italic> spp<italic>., Staphylococcus</italic> spp<italic>.</italic> and <italic>Ureaplasma</italic> spp., <italic>Haemophilus</italic> spp<italic>., Moraxella</italic> spp<italic>., Streptococcus</italic> spp<italic>., Staphylococcus</italic> spp<italic>., Tropheryma whipplei,</italic> bacteriophages, <italic>Anelloviridae, Systenosterma, Erethecium</italic> and <italic>Malassezia</italic> genera</td></tr><tr><td>Cardiovascular system</td><td><italic>H. pylori,</italic> herpes simplex virus, <italic>Cytomegalovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae</italic>, <italic>Epstein Barr virus</italic></td><td>–</td><td>Clifford and Hoffman (<xref ref-type="bibr" rid="CR19">2015</xref>)</td></tr><tr><td>Urinary system</td><td><italic>Corneybacterium, Escherichia, Ureaplasma, Mycoplasma, enterococcus, Aerococcus, Staphylococcus, Gemella, Anaerococcus, Prevotella</italic>, <italic>Finegoldia</italic>., <italic>Actinobaculum, Aerococcus, Anaerococcus, Gardnerella, Bulkholderia, Corneybacterium, Bifidobacterium, Actinobacteria, Bacteroidetes, Rhodobacter, Alloscardovia, Trueperella, Atopobium, Sneathia, Enterobacteriaceae, Shigella</italic>, <italic>Prevotella</italic>., <italic>Saccharofermentans, Proteiniphilum, Parvimonas</italic> and <italic>Jonquetella</italic></td><td>2.11 Mb</td><td>Nayfasch and Pollard (2015)</td></tr></tbody></table></table-wrap></p>
<p id="Par5">The principal constituents are the bacteriome, virome and mycobiome, whose strong interdependence maintains the functionality of the gut microbiota, if imbalanced may also affect the other systems in various ways. Since the time of birth of an individual, when the sterile gut of the neonate gets exposed to the biota of mother’s vagina during the vaginal delivery or hospital microbiota in case of caesarean section (which may even include the multidrug-resistant species), the microbes starts their colonisation with an eventual change by the age of 3–5 years, by when an individual starts resembling bacterial community to that of an adult both structurally and functionally (Bull and Plummer <xref ref-type="bibr" rid="CR9">2014</xref>). In adults, the composition of gut microbiota is uneven throughout the length of the gut. As compared to small intestine, which is rich in the species related to phylum <italic>Firmicutes</italic>, colon on the contrary exhibits the presence of members of phylum Bacteroidetes. The microbiome of lumen and that attached to the epithelial lining even show differences. The stool sample exhibited the presence of <italic>Bacteroides, Streptococcus, Ruminococcus, Lactobacillus, Enterococcus, Bifidobacterium</italic> and <italic>Clostridium</italic> which presented the lumen community while on the mucous layer detected the presence of <italic>Enterococcus, Lactobacillus</italic> and <italic>Clostridium</italic> (Swidsinski et al. <xref ref-type="bibr" rid="CR92">2005</xref>).</p>
</sec>
<sec id="Sec4">
<title>The Microbiome of the Lungs and the Airways</title>
<p id="Par6">During the initiation of HMP, the airways and lungs were exempted from the study, believing these parts to be sterile in nature (Moffatt and Cookson <xref ref-type="bibr" rid="CR66">2017</xref>). This fact was always acceptable because of the negative results yielded by the various standard microbiological culture tests of the healthy individuals (Faner et al. <xref ref-type="bibr" rid="CR30">2017</xref>). Its study was also a challenge owing to the difficulty in assessing the lower tract without the invasive techniques such as bronchoscopy. Hence, there has been a delay in the systemic microbiome assay until the first study indicating the similarity of bacterial density of this part with the upper small bowel of human body was reported (Man et al. <xref ref-type="bibr" rid="CR61">2017</xref>). This has been made possible due to the advances in molecular techniques independent of culture practices (Faner et al. <xref ref-type="bibr" rid="CR30">2017</xref>). Human respiratory system is divided into upper respiratory tract (URT) and lower respiratory tract (LRT) with alveoli, present in the LRT, acquiring the surface area nearly 70 m<sup>2</sup> (Man et al. <xref ref-type="bibr" rid="CR61">2017</xref>). This complete tract is occupied by the niche-specific microbiota with higher density dwelling in URT.</p>
<p id="Par7">The development of microbiota has been thought to effect on the morphological genesis of this system (Man et al. <xref ref-type="bibr" rid="CR61">2017</xref>). During the first hours of a healthy neonate, non-specific microbes, presumed of maternal origin has been detected. Abundance of <italic>Staphylococcus</italic> spp. in the first week, in the URT due to niche specification, has also been detected, which is then occupied by the <italic>Corynebacterium</italic> spp., dominated by the <italic>Dolosigranulum</italic> spp. The <italic>Moraxella</italic> species has its dominance at the age of 4–6 months. The individuals with the possession of such microbiota have been found to possess stable microbiome community along with better airway health (Morris et al. <xref ref-type="bibr" rid="CR68">2013</xref>; Segal et al. <xref ref-type="bibr" rid="CR86">2013</xref>) This healthy development is prone to disturbance under certain conditions such as usage of antibiotics, oxygen tension, temperature and pH, presence of other siblings, seasonal variations, vaccinations, exposure to smoke and host genetics (Man et al. <xref ref-type="bibr" rid="CR61">2017</xref>). Attempt to observe the diversity of flora in URT and LRT is well observed (Table <xref ref-type="table" rid="Tab1">20.1</xref>).</p>
</sec>
<sec id="Sec5">
<title>The Microbiome of the Cardiovascular System</title>
<p id="Par8">Studies using species specific molecular techniques have declared that the disease-free arteries and veins are microbe free in nature (Jin et al. <xref ref-type="bibr" rid="CR45">2019</xref>; Sobol <xref ref-type="bibr" rid="CR91">2014</xref>). Very few studies do report the presence of bacterial and viral genome in some vessels of healthy subjects. Amongst the microbes, <italic>Helicobacter pylori</italic> and herpes simplex virus are the most prevalent followed by <italic>Cytomegalovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae</italic> and <italic>Epstein Barr virus</italic> and were also detected in healthy aorta, saphenous veins and internal mammary arteries (Clifford and Hoffman <xref ref-type="bibr" rid="CR19">2015</xref>).</p>
</sec>
<sec id="Sec6">
<title>The Microbiome of the Cardiovascular System</title>
<p id="Par9">Studies using species-specific molecular techniques have declared that the disease-free arteries and veins are microbe free in nature (Jin et al. <xref ref-type="bibr" rid="CR45">2019</xref>; Sobol <xref ref-type="bibr" rid="CR91">2014</xref>). Very few studies do report the presence of bacterial and viral genome in some vessels of healthy subjects. Amongst the microbes, <italic>Helicobacter pylori</italic> and herpes simplex virus are the most prevalent followed by <italic>Cytomegalovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae</italic> and <italic>Epstein Barr virus</italic> and were also detected in healthy aorta, saphenous veins and internal mammary arteries (Clifford and Hoffman <xref ref-type="bibr" rid="CR19">2015</xref>).</p>
</sec>
<sec id="Sec7">
<title>Urogenital Microbiome</title>
<p id="Par10">The human urinary tract along with urine was earlier considered to be ‘sterile’, until the modern-day research, which has confirmed the presence of microbes in this system, significantly in healthy individuals. The advances in techniques such as 16 s rRNA sequencing have considerably helped in revealing the normal microbiota of the human body system. After analysis of the urine, the most common genera reported are <italic>Lactobacillus</italic> (more in women) and <italic>Streptococcus</italic> (more in men), both of which, along with few other groups, deliver a protective role in this system against different pathogens. Various bacterial taxa, as illustrated (Table <xref ref-type="table" rid="Tab1">20.1</xref>), had been recognised in healthy adults, but some specific genera such as <italic>Saccharofermentans, Proteiniphilum, Parvimonas</italic> and <italic>Jonquetella</italic> were found in persons with age more than 70 years. The variation of urinary microbiome related to age and sex may be due to differences in voiding habits, hygiene, urinary metabolites, anatomic structures, hormonal variation and histology. Even the vaginal microbiome at premenstrual phase, reproductive age and post-menopausal phase exhibits variation (Aragón et al. <xref ref-type="bibr" rid="CR2">2018</xref>).</p>
</sec>
<sec id="Sec8">
<title>The Microbiome of the Nervous System</title>
<p id="Par11">Central nervous system is considered to be one of the most immune privileged systems because of its closed compartmentalisation. It is isolated by physical barriers like blood-brain barriers and blood-cerebrospinal fluid barriers, from the circulatory system (Obermeier et al. <xref ref-type="bibr" rid="CR71">2013</xref>; Ransohoff and Engelhardt <xref ref-type="bibr" rid="CR81">2012</xref>). Thus, lack of lymphatic drainage, expression of major histocompatibility complex by the parenchymal cells and anti-inflammatory environment of the central nervous system accounts for such privileged status of seclusion from the microbiota (Berer and Krishnamoorthy <xref ref-type="bibr" rid="CR5">2014</xref>).</p>
<p id="Par12">Though, in our body, there exists a bidirectional communication system, involving hormonal, immunological and neural signalling pathways, between the brain and the gut, accessed by the microbial flora of the intestine and certain metabolites, also known as the gut-brain axis. It is estimated that nearly 90% of serotonin (5-HT), a neurotransmitter, is produced in the intestine under the influence of gut microbiota, and the activation of its receptors in the enteric nervous system is responsible for the neuroprotection and adult neurogenesis in the mouse model (De Vadder et al. <xref ref-type="bibr" rid="CR24">2018</xref>).</p>
</sec>
<sec id="Sec9">
<title>The Microbiome of the Skin</title>
<p id="Par13">The largest organ forming the external interface of the human body to the environment is the skin. Nearly 1.5–2.0 m<sup>2</sup> of the skin covers an average human with 2–3 mm depth. Three tissue layers are found in the skin: epidermis, dermis and hypodermis. Epidermis is colonised by millions of the microbes such as bacteria, fungi, arthropods and even viruses. It acts as the physical, anatomical and immunological barrier to various pathogens extending protection of the body, unless this barrier is broken or there is an imbalance between commensal and pathogenic organisms resulting to cutaneous or systemic diseases. Their acidic pH, continuous shedding of epidermal cells, hydrophobic nature, salinity and association with the antimicrobial compounds make them an efficient barrier (Ross et al. <xref ref-type="bibr" rid="CR83">2017</xref>). Though microbes do exist on them in spite of the above characteristics, the number of microbes inhabiting the skin ranges from one million to about one billion in each cm<sup>2</sup>. Although, human skin is inhabited by quite diverse microflora, but most commonly found bacterial phyla includes <italic>Proteobacteria, Corynebacteria, Propionibacteria, Bacteroidetes, Firmicutes and Staphylococcus</italic> spp. Amongst fungi, <italic>Malassezia</italic> spp<italic>., Cryptococcus</italic> spp<italic>., Epiciccum</italic> spp<italic>., Aspergillus</italic> spp<italic>.</italic> and <italic>Rhodotorula</italic> spp. are most commonly found. The factors that affect the prevalence and dominance of community on the skin include biological sex, skin depth, skin location (skin thickness, folds, density of hairs), age, health, geographical location, ethnicity, use of lotions, soaps, cosmetics, and antibiotics and hygiene practices.</p>
</sec>
</sec>
<sec id="Sec10">
<title>Influence of Microbiome on Human Health</title>
<p id="Par14">As humans are known to have a constant symbiosis with microorganisms, the human microbial community, inhabiting the various system exhibits their influence on them. There are nearly 100 trillion symbiotic microorganisms that exist on and within the human body and have shown to play very important roles both in human health and disease causation. The influence of this microbiome on various systems is as follows:</p>
<sec id="Sec11">
<title>Influence of Microbiome on Maintenance of Human-Gut Environment</title>
<p id="Par15">Amongst all the systems, the highest and heterogeneous microbial density resides in colon and is mostly codependent in nature and present along both longitudinal (proximal to distal) and axial (mucosal to lumen) gradients of the gastrointestinal (GI) tract. The microbiome has been reported to aid in food digestion, vitamin biosynthesis, bile acid biotransformation, building of innate immunity, maintenance of intestinal barrier (Valdes et al. <xref ref-type="bibr" rid="CR103">2018</xref>), etc. Thus, gut is an “essential organ”, carrying approximately 150 times more genes than are found in the entire human genome (Wang et al. <xref ref-type="bibr" rid="CR106">2017</xref>) (Fig. <xref ref-type="fig" rid="Fig1">20.1</xref>).<fig id="Fig1"><label>Fig. 20.1</label><caption><p>Schematic diagram showing the role of the gut microbiota in health and disease with some inputs and outputs. <italic>CVD</italic> cardiovascular disease, <italic>IPA</italic> indole propionic acid, <italic>LPS</italic> lipopolysaccharide, <italic>SCFA</italic> short-chain fatty acids, <italic>TMAO</italic> trimethylamine-N-oxide</p></caption><graphic id="MO1" xlink:href="479265_1_En_20_Fig1_HTML"></graphic></fig></p>
<sec id="Sec12">
<title>Metabolism</title>
<p id="Par16">Microbial inhabitants within the host often contribute to metabolism such as:<list list-type="bullet"><list-item><p id="Par17">Bile salt metabolism</p></list-item><list-item><p id="Par18">Synthesis of essential and non-essential amino acids</p></list-item><list-item><p id="Par19">Replication of virulence factors in enteric pathogen</p></list-item><list-item><p id="Par20">Pro-drug transformation into active drugs and</p></list-item><list-item><p id="Par21">Metabolism of xenobiotic compounds</p></list-item><list-item><p id="Par22">Antibiotics by chemical transformation (Sarkar et al. <xref ref-type="bibr" rid="CR84">2018</xref>)</p></list-item></list></p>
<p id="Par23">Gut microbiota and host interaction result in the secretion of a series of metabolites including trimethylamine-N-oxide (TMAO); short-chain fatty acid (SCFA) such as acetate and butyrate; secondary bile acid; and indoxyl sulphates that activate numerous signalling pathways affecting host physiological processes (Jin et al. <xref ref-type="bibr" rid="CR45">2019</xref>).</p>
</sec>
<sec id="Sec13">
<title>Contribution Towards the Host Immune System</title>
<p id="Par24">When a child is born, the immune system at birth is under a relative state of immaturity. The developing immune system is characterised by a skewed T- and B-cell development and a blunted inflammatory cytokine production with respect to the regulatory responses. The consequence of such an underdeveloped immune system is high susceptibility to infections. Thereby, the regulatory environment ensures the establishment of the microbiota which ultimately helps in immune regulation and limits the mucosal inflammation following their colonisation (Elahi et al. <xref ref-type="bibr" rid="CR29">2013</xref>).</p>
<p id="Par25">Many intestinal bacteria also prevent the colonisation of pathogen by producing antimicrobial substances such as bacteriocin (inhibit pathogen growth), by competing for nutrition and attachment sites. This act is termed as barrier/competitive-exclusion effect (Collado et al. <xref ref-type="bibr" rid="CR20">2010</xref>). Exposure to intestinal bacteria has also been found to prevent certain allergic responses in the hosts.</p>
<p id="Par26">Thereby, the commensals, specifically the bacterial species and the products or metabolites derived from them, are considered as an intrinsic regulator of all the immune responses for the upliftment and restoration of human meta-organism’s health (Belkaid and Hand <xref ref-type="bibr" rid="CR4">2014</xref>).</p>
</sec>
<sec id="Sec14">
<title>Gut Microbiota and Associated Diseases</title>
<p id="Par27">Gut bacteria are intrinsically linked with the health of our entire body. However, a change in gut microbiota composition, termed as dysbiosis, can result in enhanced susceptibility of the host towards pathology. Dysbiosis can cause various diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), chronic kidney disease (CKD), cardiovascular disease (CVD), atherosclerosis, obesity, autism, allergy, asthma, hypertension, coronary artery disease, and heart failure (Tang and Hazen <xref ref-type="bibr" rid="CR94">2017</xref>; Backhed, et al., 2012).</p>
<sec id="Sec15">
<title>Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)</title>
<p id="Par28">IBS and IBD are related to bowel disorder with signs and symptoms of abdominal cramping, pain and bloating associated with features of disordered defecation in IBS and ongoing inflammation of all part of GI tract in IBD. Although IBS is a multifactorial disease (Soares <xref ref-type="bibr" rid="CR90">2014</xref>), intestinal dysbiosis has also been found associated with this disease by facilitating adhesion of enteric pathogens. IBD includes Crohn’s disease (CD) and ulcerative colitis (UC). Gut microbiota has been implicated to have roles in IBD pathogenesis, and the usage of antibiotics may help in reducing inflammation or prevented the same in murine models of disease and in patients.</p>
</sec>
<sec id="Sec16">
<title>Chronic Kidney Disease (CKD)</title>
<p id="Par29">Intestinal dysbiosis is most often accompanied by defective intestinal barrier function, which promotes the production of bacterial by-products that are rapidly absorbed and retains in intestinal lumen. When increased absorption is coupled with reduced clearance of these substances by the kidneys, levels of gut derived toxins rise in circulation and may potentiate vascular calcification, atherosclerosis and adverse cardiovascular functioning, which are the clinical conditions in the later stage of CKD. Numerous epidemiologic studies have shown a relationship between gut-derived vascular toxins and cardiovascular events in patient with CKD (Valdes et al. <xref ref-type="bibr" rid="CR103">2018</xref>).</p>
</sec>
<sec id="Sec17">
<title>Gut Microbiome–Associated Cardiovascular Disease (CVD)</title>
<p id="Par30">Metabolic origin of traditional CVD risk factors such as obesity, dyslipidaemia and insulin resistance indicates close linkage between the gut microbiome and CVD. Recent studies have implicated that atherosclerosis has generated the largest amount of data in association with gut microbiome. According to a hypothesis, gut microbiota metabolites elicit inflammatory cascade by translocating into bloodstream and promote atherosclerosis. Oral bacteria causing oral cavities have also been found in atherosclerosis plaque (Clifford and Hoffman <xref ref-type="bibr" rid="CR19">2015</xref>). In many CVDs, heart failure is considered as end stage with a higher rate of morbidity and mortality (Jin et al. <xref ref-type="bibr" rid="CR45">2019</xref>). Low intestinal perfusion and disruption of intestinal barrier have been reported as reasons for reduced cardiac output and blood redistribution. The translocation of microbiota and endotoxins into blood circulation leads to an aggravated systemic inflammation that further can lead to increased chances of heart failure (Peng et al. <xref ref-type="bibr" rid="CR78">2018</xref>).</p>
<p id="Par31">Various studies suggested the direct and indirect link between gut microbiota and the development of hypertension (Jin et al. <xref ref-type="bibr" rid="CR45">2019</xref>). It is a complex clinical condition and can be influenced by number of factors. It is considered as modifiable risk factor for CVD. In some studies, <italic>Prevotella, Faecalibacterium, Klebsiella, Clostridium</italic> and <italic>Streptococcus</italic> are found in abundance in hypertensive patients, indicating a close association of host microflora to such a clinical condition. Other studies demonstrated that reduction in gut microbial diversity, short-chain fatty acid (SCFA)-producing bacteria and increase in sympathetic drive to the gut and lactic acid producing bacteria, respectively, have direct role in blood pressure regulation. Thus, it can be concluded that blood pressure is closely linked to diversity, richness and evenness of microbiome living in the gut and the improved gut microbiota may be a target for future therapies for hypertension (Peng et al. <xref ref-type="bibr" rid="CR78">2018</xref>).</p>
</sec>
<sec id="Sec18">
<title>Human Nervous System Association with Gut Microbiota</title>
<p id="Par32">The gut-brain axis plays a major role in central nervous system (CNS) and intestinal and immune system functioning, as mentioned earlier. Gut-brain axis is the bidirectional biochemical signalling between GI and CNS activities, integrating efferent and afferent neural, endocrine, nutrient and immunological signals, providing gut microbiota and its derived metabolites a route to access the brain (Bull and Plummer <xref ref-type="bibr" rid="CR9">2014</xref>; Joscelyn and Kasper <xref ref-type="bibr" rid="CR46">2014</xref>). Wang and Kasper illustrated that this bidirectional communication system enables brain to command GI functions such as metabolism, peristalsis, mucin production and other immunological functions.</p>
<p id="Par33">Gut microbiota is also found to have impact on hypothalamic-pituitary-adrenal (HPA) axis, thus playing a role in body’s stress response (Gareau et al. <xref ref-type="bibr" rid="CR33">2008</xref>; Teitelbaum et al. <xref ref-type="bibr" rid="CR96">2008</xref>). The gut microbiota has also been shown to synthesise neurotransmitters and neuromodulators. Various neurotransmitters produced by bacterial species are presented in Table <xref ref-type="table" rid="Tab2">20.2</xref>. Those released neurotransmitter then stimulates epithelial cells to synthesise modulators within the enteric nervous system (ENS) or directly acting on primary afferent axons (McVey Neufeld et al. <xref ref-type="bibr" rid="CR63">2013</xref>). Moreover, it has been shown that ENS plays a major role in fundamental gastrointestinal physiological functions such as motility, fluid secretions and blood flow. Furthermore, numerous studies have revealed the correlation between microbiome, microbiota derived products, antibiotics, prebiotics and probiotics and CNS (Wang and Kasper <xref ref-type="bibr" rid="CR105">2014</xref>).<table-wrap id="Tab2"><label>Table 20.2</label><caption><p>Various neurotransmitters synthesised by different bacterial species</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Bacterial species</th><th>Neurotransmitter</th></tr></thead><tbody><tr><td><italic>Lactobacillus</italic> spp.</td><td>Gamma-amino butyric acid (GABA), acetylcholine</td></tr><tr><td><italic>Bifidobacterium</italic> spp.</td><td>Gamma-amino butyric acid (GABA)</td></tr><tr><td><italic>Escherichia</italic> spp.</td><td>Norepinephrine (NE), 5-hydroxy tryptamine-serotonin (5-HT)</td></tr><tr><td><italic>Bacillus</italic> spp.</td><td>Norepinephrine (NE), dopamine (DA)</td></tr><tr><td><italic>Streptococcus</italic> spp.</td><td>5-HT</td></tr><tr><td><italic>Enterococcus</italic> spp.</td><td>5-HT</td></tr></tbody></table></table-wrap></p>
<p id="Par34">Anxiety and stress, characteristic mood disorders, associated with nervous, endocrinal and immunological system have also been shown to have an association with the gut microbiota. Stressors such as chemical, biological or any environmental stimuli can act as an active component to trigger the anxiety and stress response which ultimately activates the hypothalamic pituitary adrenal (HPA) axis. Intestinal dysbiosis and gut pathogens have thereby been shown to cause stress and anxiety. Animal models have represented to ameliorate these disorders by using probiotic formulations (Messaoudi et al. <xref ref-type="bibr" rid="CR65">2011</xref>). Various output and input of role of gut microbiota is depicted in Fig. <xref ref-type="fig" rid="Fig2">20.2</xref>.<fig id="Fig2"><label>Fig. 20.2</label><caption><p>Structures of human respiratory tract, the upper respiratory tract and the lower respiratory tract along with their prevalent microbiota</p></caption><graphic id="MO2" xlink:href="479265_1_En_20_Fig2_HTML"></graphic></fig></p>
</sec>
</sec>
</sec>
</sec>
<sec id="Sec19">
<title>Microbiome as a Paradigm for Future Nutritional and Medicinal Strategies</title>
<p id="Par35">The analysis of microbiome of human body shows both the pathogenic as well as beneficial microbial network (Ozturk et al. <xref ref-type="bibr" rid="CR76">2017</xref>). Customizable medicine based on an individual’s microbiome is an excellent approach for therapeutic choices based either on exercises or/and medications which considers the genetic makeup of an individual, their health condition and quality of life (Hasani-Ranjbar and Larijani <xref ref-type="bibr" rid="CR39">2017</xref>). Human genomes are about 99.9% indistinguishable to one another; the generally steady human gene pool does not completely clarify all the phenotypic varieties amongst people. On the other hand, the bacterial biological system, living in each human body, that contributes multiple times larger number of qualities than the human genome, could be significantly unique in relation to an individual. Therefore, the human microbiome can be regarded as the true cause of numerous responses that can influence the structure and plenitude of microorganism (Hasani-Ranjbar and Larijani <xref ref-type="bibr" rid="CR39">2017</xref>) in the human body.</p>
<p id="Par36">Recently various studies have shown that intestinal microbiota is fundamentally associated with various therapeutics as in cardiovascular diseases, cancer, etc. These include narrow spectrum antibiotics along with probiotics, prebiotics and synbiotics, faecal microbiota transplantation, nutritional modulators, immune modulators and phage therapy.</p>
<sec id="Sec20">
<title>Effects of Antibiotic Abuse on Microbiota</title>
<p id="Par37">In the USA and Europe, jointly, in the year 2015, because of the onset of antibiotic resistance amongst pathogens, around 50,000 deaths were witnessed, which was projected to increase to a score of around ten million deaths per year worldwide by 2050 (Langdon et al. <xref ref-type="bibr" rid="CR53">2016</xref>).</p>
<p id="Par38">In addition to the development of resistance, the usage of antibiotics has been reported to disrupt the ecology of the human microbiome. Whereby, a dysbiotic microbiome loses the capability to perform vital functions such as nutrient supply, production of vitamin, and defence against the pathogens; thereby it leads to an eventual impairment of the metabolic, immunological and developmental system of the host. For an instance, drug-induced modification of the gut microflora can influence a group of Foxp3<sup>+</sup>Treg cells that control demyelination in exploratory autoimmune encephalomyelitis (EAE) (Ochoa-Repáraz et al. <xref ref-type="bibr" rid="CR72">2010</xref>). Another study reflects the antigens produced by <italic>Bacteroides fragilis</italic> (capsule polysaccharide) can protect against EAE (CNS demyelination) and further in human multiple sclerosis (Ochoa-Repáraz et al. <xref ref-type="bibr" rid="CR73">2011</xref>). Similarly, the effects of common antimicrobial treatments on the gut microbiota have been illustrated in Table <xref ref-type="table" rid="Tab3">20.3</xref>.<table-wrap id="Tab3"><label>Table 20.3</label><caption><p>Effects of commonly used antimicrobials on gut microbiota</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Antimicrobial class</th><th rowspan="2">Antimicrobial agent</th><th colspan="3">Effects on faecal microbiota count</th><th rowspan="2">Reference</th></tr><tr><th>Decrease in no. of microbiota</th><th>Increase in no. of microbiota</th><th>Constant no. of microbiota</th></tr></thead><tbody><tr><td rowspan="2"><bold>Penicillin</bold></td><td>Piperacillin, tazobactum</td><td><italic>Bifidobacteria, Eubacteria, Lactobacilli, Enterobacter cloacae</italic></td><td><italic>Klebsiella pneumoniae</italic></td><td>Enterococci clostridia, Bacteroides</td><td>Morjaria et al. (<xref ref-type="bibr" rid="CR67">2019</xref>) and Bhalodi et al. (<xref ref-type="bibr" rid="CR7">2019</xref>)</td></tr><tr><td>Ampicillin</td><td></td><td><italic>Enterobacter cloacae, Klebsiella pneumonia</italic></td><td></td><td>Kamal et al. (<xref ref-type="bibr" rid="CR47">2019</xref>)</td></tr><tr><td rowspan="3"><bold>Cephalosporins</bold></td><td>Cefuroxime</td><td><italic>Enterobacter cloacae</italic></td><td></td><td><italic>Klebsiella pneumoniae</italic></td><td>Kamal et al. (<xref ref-type="bibr" rid="CR47">2019</xref>)</td></tr><tr><td>Cefotaxime</td><td>Firmicutes, Actinobacteria, Bacteroidetes</td><td></td><td>Proteobacteria</td><td>Burdet et al. (<xref ref-type="bibr" rid="CR10">2019</xref>)</td></tr><tr><td>Ceftriaxone</td><td>Firmicutes, Actinobacteria, Bacteroidetes</td><td></td><td>Proteobacteria</td><td>Burdet et al. (<xref ref-type="bibr" rid="CR10">2019</xref>)</td></tr><tr><td><bold>Carbapenems</bold></td><td>Meropenem</td><td></td><td>Actinobacteria Proteobacteria</td><td></td><td>Ye et al. (<xref ref-type="bibr" rid="CR109">2019</xref>)</td></tr><tr><td><bold>Fluoroquinolones</bold></td><td>Ciprofloxacin</td><td></td><td></td><td><italic>Klebsiella pneumonia Enterobacter cloacae</italic></td><td>Kamal et al. (<xref ref-type="bibr" rid="CR47">2019</xref>)</td></tr><tr><td><bold>Aminoglycosides</bold></td><td>Gentamicin</td><td></td><td><italic>Enterobacter cloacae</italic></td><td><italic>Klebsiella pneumoniae</italic></td><td>Kamal et al. (<xref ref-type="bibr" rid="CR47">2019</xref>)</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec21">
<title>Probiotics</title>
<p id="Par39">Probiotics are characterised as live microorganisms which are not part of the human host microbiome yet give a medical advantage to the host when administered or directed in sufficient quantity. Probiotics have been extensively studied in recent years as it imparts various health benefits by the metabolites it produces in the relief from certain intestinal disorders as well as controlling EAE. Clinical trials have been able to demonstrate that certain cardio metabolic disorders (CMD), such as type 2 diabetes mellitus (T2D), dyslipidaemia and arterial hypertension, as well as chronic kidney diseases (CKD) can be managed by the ingestion of probiotics (Neto et al. <xref ref-type="bibr" rid="CR70">2018</xref>). <italic>Saccharomyces boulardii</italic> has been shown to exert anti-inflammatory effect which helps to control inflammation related to the dysbiosis in lumen (Rodríguez-Nogales et al. <xref ref-type="bibr" rid="CR82">2018</xref>). Various metabolites produced by microorganisms present in the host and its associated health benefits are discussed in Table <xref ref-type="table" rid="Tab4">20.4</xref>.<table-wrap id="Tab4"><label>Table 20.4</label><caption><p>Metabolites-producing microbiota and its associated health benefits</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Microorganisms</th><th>Metabolites</th><th>Health benefits</th><th>References</th></tr></thead><tbody><tr><td><italic>Bacteroides fragilis</italic></td><td>Polysaccharide A</td><td>Controls EAE and IBD by promoting Foxp3<sup>+</sup>Treg quantity</td><td>Ochoa-Repáraz et al. (<xref ref-type="bibr" rid="CR72">2010</xref>)</td></tr><tr><td><italic>Lactobacilli Bifidobacteria</italic></td><td>Lactic acid</td><td>Anti-inflammatory, promotes IL-10<sup>+</sup>Foxp3<sup>+</sup>Treg</td><td>Takata et al. (<xref ref-type="bibr" rid="CR93">2011</xref>) and Kwon et al. (<xref ref-type="bibr" rid="CR52">2013</xref>)</td></tr><tr><td><italic>Escherichia coli</italic></td><td>Vitamin B</td><td>Prevents vitamin K-deficiency bleeding, lower risk of type 2 diabetes</td><td>Tursunov et al. (<xref ref-type="bibr" rid="CR101">2018</xref>), and Díaz-Rizzolo et al. (<xref ref-type="bibr" rid="CR25">2019</xref>)</td></tr><tr><td><italic>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium breve,</italic></td><td>Complex vitamin B</td><td>Maintains the immune system, prevents cardiovascular diseases, chronic kidney diseases and improves nervous system</td><td>Yoshii et al. (<xref ref-type="bibr" rid="CR111">2019</xref>), Sivamaruthi et al. (<xref ref-type="bibr" rid="CR89">2019</xref>), Kobayashi et al. (<xref ref-type="bibr" rid="CR49">2019</xref>), and Jena et al. (<xref ref-type="bibr" rid="CR44">2018</xref>)</td></tr><tr><td><italic>Bacteroides</italic></td><td>Propionate and butyrate</td><td>Relieves from intestinal problems, relieves from tuberculosis</td><td>De Paepe et al. (<xref ref-type="bibr" rid="CR23">2018</xref>) and Maji et al. (<xref ref-type="bibr" rid="CR60">2018</xref>)</td></tr><tr><td><italic>Propionibacteria</italic></td><td>Propionate</td><td>Protects colon mucosa cells and prevents cancer, Prevent diarrhoea</td><td>Casanova et al. (<xref ref-type="bibr" rid="CR14">2018</xref>) and Gaucher et al. (<xref ref-type="bibr" rid="CR34">2019</xref>)</td></tr><tr><td><italic>Veillonella, Bacteroides, Coprococcus, Lactobacillus, Ruminococcus</italic></td><td>Acetate, lactate and propionate</td><td>Ecological performance of intestine is increased</td><td>El Hage et al. (<xref ref-type="bibr" rid="CR28">2019</xref>)</td></tr><tr><td><italic>Streptococcus thermophilus</italic></td><td>Folic acid</td><td>Cures intestinal mucositis, has anti-cancer activity, promotes gut-bone signalling</td><td>Levit et al. (<xref ref-type="bibr" rid="CR57">2018</xref>), Tarrah et al. (<xref ref-type="bibr" rid="CR95">2018</xref>), and Schepper et al. (<xref ref-type="bibr" rid="CR85">2017</xref>)</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec22">
<title>Prebiotics and Synbiotics</title>
<p id="Par40">Prebiotics are those food components that cannot be digested by human body but can be selectively digested by the members of probiotics, and thereby serves as a food fibre for probiotics. Recent studies have demonstrated that the use of prebiotics can result in enhancing the ecological performance of the gut microbiota, thus promoting a much more beneficial community (Vandeputte et al. <xref ref-type="bibr" rid="CR104">2017</xref>). This conceptualizes that the human microbiota can be enhanced, stabilised and shifted by feeding with certain specific prebiotics such as carbohydrates. However, characterisation of the relationship between the prebiotic and probiotic is still a challenge. The point when the idea of synbiotic was first presented, two setups were proposed: first, where the prebiotic and probiotic segments were independent, each being in charge of a specific impact or medical advantage, and second, a symbiotic segment, where the probiotic was explicitly structured with a prebiotic substrate that would synergistically support the intensity, survival or metabolic movement of a related probiotic strain in the ecology of gastrointestinal system (Krumbeck et al. <xref ref-type="bibr" rid="CR51">2016</xref>).</p>
<p id="Par41">As of late, two novel methodologies have been proposed for creating such synergistic synbiotics, both being dependent on their ecological function and wellness. First, the in vivo strategy which depends upon the determination and isolation of probiotic strain that would increase in number when a certain population of participants are administered with the specific prebiotic component (Krumbeck et al. <xref ref-type="bibr" rid="CR50">2015</xref>). Second, called as a multi-taxon insertion, depending on sequencing, based on the identification of genes, would examine the fitness of probiotic strain in relation to the type of prebiotic administered by the usage of libraries of transposon mutants (Wu et al. <xref ref-type="bibr" rid="CR107">2015</xref>). A list of prebiotics with their probiotic components are given in Table <xref ref-type="table" rid="Tab5">20.5</xref>.<table-wrap id="Tab5"><label>Table 20.5</label><caption><p>List of prebiotic and its specific probiotic components</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Prebiotic</th><th>Probiotic microorganisms</th><th>References</th></tr></thead><tbody><tr><td>Inulin-type fructans</td><td><italic>Anaerostipes, Bilophila and Bifidobacterium</italic></td><td>Vandeputte et al. (<xref ref-type="bibr" rid="CR104">2017</xref>)</td></tr><tr><td>Galacto-oligosaccharides</td><td><italic>Bifidobacterium</italic></td><td>Canfora et al. (<xref ref-type="bibr" rid="CR12">2017</xref>)</td></tr><tr><td>Resistant Starch</td><td><italic>Bifidobacterium,</italic> Proteobacteria</td><td>Alfa et al. (<xref ref-type="bibr" rid="CR1">2018</xref>)</td></tr><tr><td>Xylooligosaccharide</td><td><italic>Blautia hydrogenotrophica; Bifidobacterium</italic></td><td>Long et al. (<xref ref-type="bibr" rid="CR59">2019</xref>) and Carlson et al. (<xref ref-type="bibr" rid="CR13">2017</xref>)</td></tr><tr><td>Whole fibre and pure inulin</td><td>Collinsella</td><td>Carlson et al. (<xref ref-type="bibr" rid="CR13">2017</xref>)</td></tr><tr><td>Fructooligosaccharides</td><td>Lactobacillaceae; Bifidobacterium</td><td>Chen et al. (<xref ref-type="bibr" rid="CR16">2017</xref>)</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec23">
<title>Faecal Microbiota Transplantation</title>
<p id="Par42">Sometimes the mere usage of antibiotics is insufficient to treat few diseases and rather requires urgent alternatives to manage the severity of the clinical condition. This has led to the introduction of transplantation of the faecal microbiota. The process involves the separation and delivery of the faecal microbiota from stool of healthy donor to the gastrointestinal tract of the receiver patient, thereby enabling an efficient cure by normalising the microbiota composition. Recent investigations have explained the mechanism behind the faecal microbiota transplantation (FMT), which has been used to treat <italic>Clostridium difficile</italic> infection (CDI) for the restoration of the gut microbiome to gain the ability to inhibit <italic>Clostridium difficile</italic> indirectly by competing for nutrients. The faecal microbiota also prevents the colonisation by unwanted microorganism by the activation of immune system as well as by direct release of certain antimicrobial components and other metabolites that helps in the inhibition of vegetative and as well as the sporulated disease-causing organism (Khoruts and Sadowsky <xref ref-type="bibr" rid="CR48">2016</xref>). Table <xref ref-type="table" rid="Tab6">20.6</xref> shows the list of diseases and infections which can be treated by using FMT.<table-wrap id="Tab6"><label>Table 20.6</label><caption><p>Diseases and infections treated by FMT</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Disease/infection</th><th>Mechanism</th><th>References</th></tr></thead><tbody><tr><td>Clostridium difficile infection (CDI)</td><td>Competition for nutrients; direct suppression by antimicrobial peptides; bile-acid-mediated inhibition of spore germination and vegetative growth; activation of immune-mediated colonisation resistance</td><td>Khoruts and Sadowsky (<xref ref-type="bibr" rid="CR48">2016</xref>)</td></tr><tr><td>Ulcerative colitis (UC)</td><td>Increasing the production of short-chain fatty acids, (butyrate); inhibitingTh1 differentiation, activity of T cells, leukocyte adhesion; production of inflammatory factors</td><td>Shen et al. (<xref ref-type="bibr" rid="CR87">2018</xref>)</td></tr><tr><td>Irritable Bowel Syndrome (IBS)</td><td>Visceral hypersensitivity; altered barrier function, gastrointestinal motility and the gut-brain axis</td><td>Grover et al. (<xref ref-type="bibr" rid="CR38">2014</xref>)</td></tr><tr><td>Obesity</td><td>Decrease adiposity; Alter metabolic phenotype by increased bacterial diversity</td><td>Marotz and Zarrinpar (<xref ref-type="bibr" rid="CR62">2016</xref>)</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec24">
<title>Nutritional Modulators</title>
<p id="Par43">Intake of dietary medications for a long period of time impacts the structure and function of microbiome of the human body. The change in the availability of nutritional content of the diet causes corresponding alteration of the human microbiome. Recent findings have suggested that depending upon the intake of dietary, the microbiome richness diversifies. The lower is the genetic richness of microbiome; the lower will be the immune status of the person, relating to abnormal metabolic function and poor anti-inflammatory activity (Cotillard et al. <xref ref-type="bibr" rid="CR22">2013</xref>; Le Chatelier et al. <xref ref-type="bibr" rid="CR55">2013</xref>). The diet patterns may even contribute in managing different diseases (Table <xref ref-type="table" rid="Tab7">20.7</xref>) by way of microbiome.<table-wrap id="Tab7"><label>Table 20.7</label><caption><p>List of diseases that may be treated by dietary interventions</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Diet pattern</th><th>Disease/infection</th><th>References</th></tr></thead><tbody><tr><td rowspan="2">High fibre diet</td><td>Obesity</td><td>Menni et al. (<xref ref-type="bibr" rid="CR64">2017</xref>)</td></tr><tr><td>Ulcerative colitis</td><td>Silveira et al. (<xref ref-type="bibr" rid="CR88">2017</xref>)</td></tr><tr><td>Fasting mimicking diet (FMD)</td><td>Multiple sclerosis and autoimmunity</td><td>Choi et al. (<xref ref-type="bibr" rid="CR18">2016</xref>)</td></tr><tr><td>Calorie restriction</td><td>EAE</td><td>Piccio et al. (<xref ref-type="bibr" rid="CR79">2008</xref>)</td></tr><tr><td>Sodium chloride restriction</td><td>Multiple sclerosis</td><td>Hernandez et al. (<xref ref-type="bibr" rid="CR41">2015</xref>)</td></tr><tr><td>Western style diet</td><td>Anxiety</td><td>Ohland et al. (<xref ref-type="bibr" rid="CR75">2013</xref>)</td></tr><tr><td>Poly unsaturated fatty acids</td><td>Depression</td><td>Gilbert et al. (<xref ref-type="bibr" rid="CR35">2013</xref>)</td></tr><tr><td>Oestrogen</td><td>Breast cancer</td><td>Chen and Madak-Erdogan (<xref ref-type="bibr" rid="CR15">2016</xref>)</td></tr><tr><td>Oleic acid</td><td>Ulcerative colitis</td><td>Fernández et al. (<xref ref-type="bibr" rid="CR31">2020</xref>)</td></tr><tr><td>Polyphenols</td><td>Obesity</td><td>Henning et al. (<xref ref-type="bibr" rid="CR40">2018</xref>)</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec25">
<title>Immune Modulators</title>
<p id="Par44">Microbiome-based approaches involving antibiotics, probiotics, prebiotics and synbiotics, faecal microbiota transplantation and nutritional modulators correlate directly with the alteration of immune status of an individual focusing on the innate immunity. Thereby, the human microbiome is being affected for benefits with the change in immune status. Until now, there are inadequate information in this method; however, treatment of inflammatory diseases using steroids is in abundance. Intestinal innate and acquired immunity as well as systemic acquired immunity involves various mechanisms for the control of gut microbiome. Some of them include change in barrier function, expression of leptin, molecule β, human leukocyte antigen (HLA) class I and class II loci, activation of toll-like receptors, natural killer cells, CD4+ cells and Foxp3+ as well as the production of antimicrobial peptides and α-defensins (Ticinesi et al. <xref ref-type="bibr" rid="CR98">2019</xref>) for the proper functioning of the gut microbiome.</p>
</sec>
<sec id="Sec26">
<title>Phage Therapy</title>
<p id="Par45">Phage therapy involves the introduction of explicit bacteriophages that targets a microorganism which in turn has the ability to generate a beneficial microbiome shift. However, a limitation to this strategy is the simultaneous resistance offered by the microorganism in play which is yet to be proven. Till date, none of the phage therapy approaches have been established as an FDA-approved drug. Recently, scientists are working hard to perform phage based killing of microbes, but it is much more complicated. CRISPR (clustered regularly interspaced short palindromic repeats) is one of the approaches to advance the limitations (LeMieux <xref ref-type="bibr" rid="CR56">2019</xref>). It is a tool derived from prokaryotic immune system empowered to study and modify organisms with ease and efficiency. The system helps to modify the gut genome of gut microorganisms and bacteriophages. This engineered CRISPR-Cas system ultimately can control gene expression and modulate production of metabolite and protein presenting a new approach for the development of drugs that can target the microbiome (Table <xref ref-type="table" rid="Tab8">20.8</xref>).<table-wrap id="Tab8"><label>Table 20.8</label><caption><p>Microbiome therapy involving CRISPR-Cas system</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Therapy model</th><th>Microbiome therapy</th><th>References</th></tr></thead><tbody><tr><td rowspan="2">Additive therapy</td><td>Probiotics (bacteria)</td><td>Hidalgo-Cantabrana et al. (<xref ref-type="bibr" rid="CR42">2017</xref>)</td></tr><tr><td>Probiotics (yeast)</td><td>Liu et al. (<xref ref-type="bibr" rid="CR58">2016</xref>)</td></tr><tr><td rowspan="2">Subtractive therapy</td><td>Lytic phages</td><td>Hwang et al. (<xref ref-type="bibr" rid="CR43">2018</xref>) and Yosef et al. (<xref ref-type="bibr" rid="CR110">2015</xref>)</td></tr><tr><td>Antimicrobials</td><td>Park et al. (<xref ref-type="bibr" rid="CR77">2017</xref>)</td></tr><tr><td rowspan="2">Modulatory therapy</td><td>Temperate phages</td><td>Park et al. (<xref ref-type="bibr" rid="CR77">2017</xref>) and Yosef et al. (<xref ref-type="bibr" rid="CR110">2015</xref>)</td></tr><tr><td>CRISPRi gene regulation</td><td>Berlec et al. (<xref ref-type="bibr" rid="CR6">2018</xref>)</td></tr></tbody></table></table-wrap></p>
</sec>
</sec>
<sec id="Sec27">
<title>Conclusion</title>
<p id="Par46">Although these interventions are used as medicinal and nutritional strategies and have been clinically experimented for a successful result, more focus and deliberate attempts are being made for the establishment of such casualty in order to define the functional metabolic change. These therapies are yet not so widely utilised due to the requirement of huge amount of money and time. Hence, advancement in this field targeting the relation of human microbiome with health and diseases, identification of the composition and activity of microbiome as well as linking it, and most importantly using technical resources such as bioinformatics to incorporate and fill up the loopholes ascertaining to the models is quite difficult. Future research based on these directions is a key to solve the problems and hence enlightening with knowledge about the human microbiome and their influence on the human health.</p>
</sec>
</body>
<back>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alfa</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Strang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tappia</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Domselaar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Forbes</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Laminman</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>DeGagne</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults</article-title>
<source/>Clin Nutr
          <year>2018</year>
<volume>37</volume>
<issue>3</issue>
<fpage>797</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="pmid">28410921</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aragón</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Herrera-Imbroda</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Queipo-Ortuño</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Castillo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Del Moral</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Gómez-Millán</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yucel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lara</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>The urinary tract microbiome in health and disease</article-title>
<source/>Eur Urol Focus
          <year>2018</year>
<volume>4</volume>
<issue>1</issue>
<fpage>128</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">28753805</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ringel</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications</article-title>
<source/>Cell Host Microbe
          <year>2012</year>
<volume>12</volume>
<issue>5</issue>
<fpage>611</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="pmid">23159051</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hand</surname>
<given-names>TW</given-names>
</name>
</person-group>
<article-title>Role of the microbiota in immunity and inflammation</article-title>
<source/>Cell
          <year>2014</year>
<volume>157</volume>
<issue>1</issue>
<fpage>121</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">24679531</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Krishnamoorthy</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Microbial view of central nervous system autoimmunity</article-title>
<source/>FEBS Lett
          <year>2014</year>
<volume>588</volume>
<issue>22</issue>
<fpage>4207</fpage>
<lpage>4213</lpage>
<pub-id pub-id-type="pmid">24746689</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berlec</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Škrlec</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kocjan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Olenic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Štrukelj</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis</article-title>
<source/>Sci Rep
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>1009</fpage>
<pub-id pub-id-type="pmid">29343791</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhalodi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>van Engelen</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Virk</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Wiersinga</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Impact of antimicrobial therapy on the gut microbiome</article-title>
<source/>J Antimicrob Chemother
          <year>2019</year>
<volume>74</volume>
<issue>Supp 1</issue>
<fpage>i6</fpage>
<lpage>i15</lpage>
<pub-id pub-id-type="pmid">30690540</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breitbart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hewson</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Felts</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mahaffy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Nulton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salamon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rohwer</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Metagenomic analyses of an uncultured viral community from human feces</article-title>
<source/>J Bacteriol
          <year>2003</year>
<volume>185</volume>
<issue>20</issue>
<fpage>6220</fpage>
<lpage>6223</lpage>
<pub-id pub-id-type="pmid">14526037</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bull</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Plummer</surname>
<given-names>NT</given-names>
</name>
</person-group>
<article-title>Part 1: the human gut microbiome in health and disease</article-title>
<source/>Integr Med Clin J
          <year>2014</year>
<volume>13</volume>
<issue>6</issue>
<fpage>17</fpage>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burdet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grall</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Linard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bridier-Nahmias</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Benhayoun</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bourabha</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Magnan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clermont</surname>
<given-names>O</given-names>
</name>
<name>
<surname>d’Humières</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tenaillon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Denamur</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Ceftriaxone and cefotaxime have similar effects on the intestinal microbiota in human volunteers treated by standard-dose regimens</article-title>
<source/>Antimicrob Agents Chemother
          <year>2019</year>
<volume>63</volume>
<issue>6</issue>
<fpage>e02244</fpage>
<lpage>e02218</lpage>
<pub-id pub-id-type="pmid">30936104</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byrd</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Segre</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The human skin microbiome</article-title>
<source/>Nat Rev Microbiol
          <year>2018</year>
<volume>16</volume>
<issue>3</issue>
<fpage>143</fpage>
<pub-id pub-id-type="pmid">29332945</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canfora</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>van der Bee</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Hermes</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Goossens</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Jocken</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Holst</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>van Eijk</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Venema</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Smidt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zoetendal</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Dejong</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Supplementation of diet with galacto-oligosaccharides increases bifidobacteria, but not insulin sensitivity, in obese prediabetic individuals</article-title>
<source/>Gastroenterology
          <year>2017</year>
<volume>153</volume>
<issue>1</issue>
<fpage>87</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">28396144</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Slavin</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Prebiotic dietary fiber and gut health: comparing the in vitro fermentations of beta-glucan, inulin and Xylooligosaccharide</article-title>
<source/>Nutrients
          <year>2017</year>
<volume>9</volume>
<issue>12</issue>
<fpage>1361</fpage>
</element-citation>
</ref>
<ref id="CR14">
<mixed-citation publication-type="other">Casanova MR, Azevedo-Silva J, Rodrigues LR, Preto A (2018) Colorectal cancer cells increase the production of short chain fatty acids by Propionibacterium freudenreichii impacting on cancer cells survival. Front Nutr 5</mixed-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Madak-Erdogan</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Estrogen and microbiota crosstalk: should we pay attention?</article-title>
<source/>Trends in Endocrinol Metab
          <year>2016</year>
<volume>27</volume>
<issue>11</issue>
<fpage>752</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="pmid">27553057</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shuai</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Prebiotic effect of fructooligosaccharides from Morinda officinalis on Alzheimer’s disease in rodent models by targeting the microbiota-gut-brain axis</article-title>
<source/>Front Aging Neurosci
          <year>2017</year>
<volume>9</volume>
<fpage>403</fpage>
<pub-id pub-id-type="pmid">29276488</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chial</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>DNA sequencing technologies key to the Human Genome Project</article-title>
<source/>Nature Education
          <year>2008</year>
<volume>1</volume>
<issue>1</issue>
<fpage>219</fpage>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Piccio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Childress</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bollman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brandhorst</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suarez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Michalsen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms</article-title>
<source/>Cell Rep
          <year>2016</year>
<volume>15</volume>
<issue>10</issue>
<fpage>2136</fpage>
<lpage>2146</lpage>
<pub-id pub-id-type="pmid">27239035</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clifford</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Evidence for a vascular microbiome and its role in vessel health and disease</article-title>
<source/>Curr Opin Rheumatol
          <year>2015</year>
<volume>27</volume>
<issue>4</issue>
<fpage>397</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">26002032</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Collado</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Gueimonde</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salminen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Probiotics in adhesion of pathogens: mechanisms of action</article-title>
<source/>Bioactive foods in promoting health
          <year>2010</year>
<publisher-loc>Chennai</publisher-loc>
<publisher-name>Academic</publisher-name>
<fpage>353</fpage>
<lpage>370</lpage>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Lauber</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fierer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Bacterial community variation in human body habitats across space and time</article-title>
<source/>Science
          <year>2009</year>
<volume>326</volume>
<issue>5960</issue>
<fpage>1694</fpage>
<lpage>1697</lpage>
<pub-id pub-id-type="pmid">19892944</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotillard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Prifti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pons</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Le Chatelier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Quinquis</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Levenez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Galleron</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gougis</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Dietary intervention impact on gut microbial gene richness</article-title>
<source/>Nature
          <year>2013</year>
<volume>500</volume>
<issue>7464</issue>
<fpage>585</fpage>
<pub-id pub-id-type="pmid">23985875</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Paepe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Verspreet</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Verbeke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Courtin</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Van de Wiele</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Introducing insoluble wheat bran as a gut microbiota niche in an in vitro dynamic gut model stimulates propionate and butyrate production and induces colon region specific shifts in the luminal and mucosal microbial community</article-title>
<source/>Environ Microbiol
          <year>2018</year>
<volume>9</volume>
<fpage>3406</fpage>
<lpage>3426</lpage>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Vadder</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Grasset</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Holm</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Macpherson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Olofsson</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks</article-title>
<source/>Proc Natl Acad Sci
          <year>2018</year>
<volume>115</volume>
<issue>25</issue>
<fpage>6458</fpage>
<lpage>6463</lpage>
<pub-id pub-id-type="pmid">29866843</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<mixed-citation publication-type="other">Díaz-Rizzolo DA, Kostov B, López-Siles M, Serra A, Colungo C, González-de-Paz L, Martinez-Medina M, Sisó-Almirall A, Gomis R (2019) Healthy dietary pattern and their corresponding gut microbiota profile are linked to a lower risk of type 2 diabetes, independent of the presence of obesity. Clin Nutr</mixed-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickson</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Erb-Downward</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Huffnagle</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>The microbiome and the respiratory tract</article-title>
<source/>Annu Rev Physiol
          <year>2016</year>
<volume>78</volume>
<fpage>481</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="pmid">26527186</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckburg</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Bik</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Purdom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dethlefsen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sargent</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Relman</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Diversity of the human intestinal microbial flora</article-title>
<source/>Science
          <year>2005</year>
<volume>308</volume>
<issue>5728</issue>
<fpage>1635</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="pmid">15831718</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Hage</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hernandez-Sanabria</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Calatayud Arroyo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Props</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Van de Wiele</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Propionate-producing consortium restores antibiotic-induced dysbiosis in a dynamic in vitro model of the human intestinal microbial ecosystem</article-title>
<source/>Front Microbiol
          <year>2019</year>
<volume>10</volume>
<fpage>1206</fpage>
<pub-id pub-id-type="pmid">31214145</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elahi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ertelt</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kinder</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chaturvedi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Qualls</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Steinbrecher</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Kalfa</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection</article-title>
<source/>Nature
          <year>2013</year>
<volume>504</volume>
<issue>7478</issue>
<fpage>158</fpage>
<pub-id pub-id-type="pmid">24196717</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<mixed-citation publication-type="other">Faner R, Sibila O, AgustÚ A, Bernasconi E, Chalmers JD, Huffnagle GB, Manichanh C, Molyneaux PL, Paredes R, Brocal VP, Ponomarenko J, Sethi S, Dorca J, Monsó E (2017) The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J 49(4):1–12</mixed-citation>
</ref>
<ref id="CR31">
<mixed-citation publication-type="other">Fernández J, García de la Fuente V, García MTF, Gómez Sánchez J, Redondo BI, Villar J, Lombó F (2020) A diet based on cured acorn-fed ham with oleic acid content promotes anti-inflammatory gut microbiota and prevents ulcerative colitis in an animal mode. Lipids Health Dis 19(28):1–19</mixed-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Oral microbiomes: more and more importance in oral cavity and whole body</article-title>
<source/>Protein Cell
          <year>2018</year>
<volume>9</volume>
<issue>5</issue>
<fpage>488</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="pmid">29736705</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gareau</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Perdue</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Pathophysiological mechanisms of stress-induced Intestina damage</article-title>
<source/>Curr Mol Med
          <year>2008</year>
<volume>8</volume>
<issue>4</issue>
<fpage>274</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="pmid">18537635</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<mixed-citation publication-type="other">Gaucher F, Bonnassie S, Rabah H, Marchand P, Blanc P, Jeantet R, Jan G (2019) Adaptation of beneficial Propionibacteria, lactobacilli, and Bifidobacteria improves tolerance toward technological and digestive stresses. Front Microbiol 10</mixed-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Arseneault-Bréard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Beaudoin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bah</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Godbout</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion</article-title>
<source/>Br J Nutr
          <year>2013</year>
<volume>109</volume>
<issue>1</issue>
<fpage>50</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">23068715</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DeBoy</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Eckburg</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Relman</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Fraser-Liggett</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Metagenomic analysis of the human distal gut microbiome</article-title>
<source/>Science
          <year>2006</year>
<volume>312</volume>
<issue>5778</issue>
<fpage>1355</fpage>
<lpage>1359</lpage>
<pub-id pub-id-type="pmid">16741115</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grice</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Segre</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The skin microbiome</article-title>
<source/>Nat Rev Microbiol
          <year>2011</year>
<volume>9</volume>
<issue>4</issue>
<fpage>244</fpage>
<pub-id pub-id-type="pmid">21407241</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grover</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Camilleri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Linden</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Farrugia</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>On the fiftieth anniversary Postinfectious irritable bowel syndrome: mechanisms related to pathogens</article-title>
<source/>Neurogastroenterol Motil
          <year>2014</year>
<volume>26</volume>
<issue>2</issue>
<fpage>156</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="pmid">24438587</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasani-Ranjbar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Larijani</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Human microbiome as an approach to personalized medicine</article-title>
<source/>Altern Ther Health Med
          <year>2017</year>
<volume>23</volume>
<issue>6</issue>
<fpage>8</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">28987073</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henning</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Grojean</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Heber</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice</article-title>
<source/>Eur J Nutr
          <year>2018</year>
<volume>57</volume>
<issue>8</issue>
<fpage>2759</fpage>
<lpage>2769</lpage>
<pub-id pub-id-type="pmid">28965248</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Kitz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lowther</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Vudattu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Herold</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kuchroo</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Kleinewietfeld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hafler</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells</article-title>
<source/>J Clin Invest
          <year>2015</year>
<volume>125</volume>
<issue>11</issue>
<fpage>4212</fpage>
<lpage>4222</lpage>
<pub-id pub-id-type="pmid">26524592</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hidalgo-Cantabrana</surname>
<given-names>C</given-names>
</name>
<name>
<surname>O’Flaherty</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barrangou</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>CRISPR-based engineering of next-generation lactic acid bacteria</article-title>
<source/>Curr Opin Microbiol
          <year>2017</year>
<volume>37</volume>
<fpage>79</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">28622636</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Yew</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Engineering microbes for targeted strikes against human pathogens</article-title>
<source/>Cell Mol Life Sci
          <year>2018</year>
<volume>75</volume>
<issue>15</issue>
<fpage>2719</fpage>
<lpage>2733</lpage>
<pub-id pub-id-type="pmid">29736607</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jena</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nagar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barile</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment</article-title>
<source/>Data Brief
          <year>2018</year>
<volume>19</volume>
<fpage>1025</fpage>
<lpage>1029</lpage>
<pub-id pub-id-type="pmid">29900399</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>The role of intestinal microbiota in cardiovascular disease</article-title>
<source/>J Cell Mol Med
          <year>2019</year>
<volume>23</volume>
<issue>4</issue>
<fpage>2343</fpage>
<lpage>2350</lpage>
<pub-id pub-id-type="pmid">30712327</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joscelyn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Digesting the emerging role for the gut microbiome in central nervous system demyelination</article-title>
<source/>Mult Scler J
          <year>2014</year>
<volume>20</volume>
<issue>12</issue>
<fpage>1553</fpage>
<lpage>1559</lpage>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamal</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Hyldig</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Krych</surname>
<given-names>Ł</given-names>
</name>
<name>
<surname>Greisen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Krogfelt</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Zachariassen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Impact of early exposure to cefuroxime on the composition of the gut microbiota in infants following cesarean delivery</article-title>
<source/>J Pediatr
          <year>2019</year>
<volume>210</volume>
<fpage>99</fpage>
<pub-id pub-id-type="pmid">31053348</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khoruts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sadowsky</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Understanding the mechanisms of faecal microbiota transplantation</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2016</year>
<volume>13</volume>
<issue>9</issue>
<fpage>508</fpage>
<pub-id pub-id-type="pmid">27329806</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kuhara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>JZ</given-names>
</name>
</person-group>
<article-title>Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial</article-title>
<source/>Benefic Microbes
          <year>2019</year>
<volume>10</volume>
<issue>5</issue>
<fpage>511</fpage>
<lpage>520</lpage>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumbeck</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Maldonado-Gomez</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Martínez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Frese</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Burkey</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Rasineni</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ramer-Tait</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Hutkins</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications</article-title>
<source/>Appl Environ Microbiol
          <year>2015</year>
<volume>81</volume>
<issue>7</issue>
<fpage>2455</fpage>
<lpage>2465</lpage>
<pub-id pub-id-type="pmid">25616794</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumbeck</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Maldonado-Gomez</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Ramer-Tait</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Hutkins</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>Prebiotics and synbiotics: dietary strategies for improving gut health</article-title>
<source/>Curr Opin Gastroenterol
          <year>2016</year>
<volume>32</volume>
<issue>2</issue>
<fpage>110</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="pmid">26825589</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jash</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response</article-title>
<source/>Clin Immunol
          <year>2013</year>
<volume>146</volume>
<issue>3</issue>
<fpage>217</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">23416238</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langdon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Crook</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dantas</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation</article-title>
<source/>Genome Med
          <year>2016</year>
<volume>8</volume>
<issue>1</issue>
<fpage>39</fpage>
<pub-id pub-id-type="pmid">27074706</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaTuga</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Cotton</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Wynn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Seed</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<issue>12</issue>
<fpage>e27858</fpage>
<pub-id pub-id-type="pmid">22174751</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Chatelier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Prifti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arumugam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Batto</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
<source/>Nature
          <year>2013</year>
<volume>500</volume>
<issue>7464</issue>
<fpage>541</fpage>
<pub-id pub-id-type="pmid">23985870</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeMieux</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Phage therapy: turning the tables on Bacteria: when engineered to incorporate CRISPR components, phages may overwhelm bacterial defenses or transform bacterial functions</article-title>
<source/>Genet Eng Biotechnol News
          <year>2019</year>
<volume>39</volume>
<issue>3</issue>
<fpage>20</fpage>
<lpage>22</lpage>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levit</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Savoy de Giori</surname>
<given-names>G</given-names>
</name>
<name>
<surname>de Moreno de LeBlanc</surname>
<given-names>A</given-names>
</name>
<name>
<surname>LeBlanc</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>Folate-producing lactic acid bacteria reduce inflammation in mice with induced intestinal mucositis</article-title>
<source/>J Appl Microbiol
          <year>2018</year>
<volume>125</volume>
<issue>5</issue>
<fpage>1494</fpage>
<lpage>1501</lpage>
<pub-id pub-id-type="pmid">29969527</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>II</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Jayakody</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Walukiewicz</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>CV</given-names>
</name>
</person-group>
<article-title>Metabolic engineering of probiotic Saccharomyces boulardii</article-title>
<source/>Appl Environ Microbiol
          <year>2016</year>
<volume>82</volume>
<issue>8</issue>
<fpage>2280</fpage>
<lpage>2287</lpage>
<pub-id pub-id-type="pmid">26850302</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Henning</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Heber</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Xylooligosaccharide supplementation decreases visceral fat accumulation and modulates cecum microbiome in mice</article-title>
<source/>J Funct Foods
          <year>2019</year>
<volume>52</volume>
<fpage>138</fpage>
<lpage>146</lpage>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maji</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dhakan</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mahato</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thukral</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Virmani</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers</article-title>
<source/>Environ Microbiol
          <year>2018</year>
<volume>20</volume>
<issue>1</issue>
<fpage>402</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="pmid">29322681</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Man</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>de Steenhuijsen Piters</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Bogaert</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The microbiota of the respiratory tract: gatekeeper to respiratory health</article-title>
<source/>Nat Rev Microbiol
          <year>2017</year>
<volume>15</volume>
<issue>5</issue>
<fpage>259</fpage>
<pub-id pub-id-type="pmid">28316330</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marotz</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Zarrinpar</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Focus: microbiome: treating obesity and metabolic syndrome with fecal microbiota transplantation</article-title>
<source/>Yale J Biol Med
          <year>2016</year>
<volume>89</volume>
<issue>3</issue>
<fpage>383</fpage>
<pub-id pub-id-type="pmid">27698622</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McVey Neufeld</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Kunze</surname>
<given-names>WA</given-names>
</name>
</person-group>
<article-title>The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse</article-title>
<source/>Neurogastroenterol Motil
          <year>2013</year>
<volume>25</volume>
<issue>2</issue>
<fpage>183</fpage>
<lpage>e88</lpage>
<pub-id pub-id-type="pmid">23181420</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Pallister</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Steves</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Valdes</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain</article-title>
<source/>Int J Obes
          <year>2017</year>
<volume>41</volume>
<issue>7</issue>
<fpage>1099</fpage>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messaoudi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lalonde</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Violle</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Javelot</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Desor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nejdi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bisson</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Rougeot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pichelin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cazaubiel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cazaubiel</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects</article-title>
<source/>Br J Nutr
          <year>2011</year>
<volume>105</volume>
<issue>5</issue>
<fpage>755</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="pmid">20974015</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moffatt</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Cookson</surname>
<given-names>WO</given-names>
</name>
</person-group>
<article-title>The lung microbiome in health and disease</article-title>
<source/>Clin Med
          <year>2017</year>
<volume>17</volume>
<issue>6</issue>
<fpage>525</fpage>
<lpage>529</lpage>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morjaria</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schluter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Littmann</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Fontana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Peled</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>van den Brink</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Taur</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Antibiotic-induced shifts in fecal microbiota density and composition during hematopoietic stem cell transplantation</article-title>
<source/>bioRxiv
          <year>2019</year>
<volume>1</volume>
<fpage>606533</fpage>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Schloss</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Crothers</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Fontenot</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Ghedin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jablonski</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Comparison of the respiratory microbiome in healthy nonsmokers and smokers</article-title>
<source/>Am J Respir Crit Care Med
          <year>2013</year>
<volume>187</volume>
<issue>10</issue>
<fpage>1067</fpage>
<lpage>1075</lpage>
<pub-id pub-id-type="pmid">23491408</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nayfach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>Average genome size estimation improves comparative metagenomics and sheds light on the functional ecology of the human microbiome</article-title>
<source/>Genome Biol
          <year>2015</year>
<volume>6</volume>
<issue>1</issue>
<fpage>51</fpage>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neto</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>de Lima Guimaraes</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Magnani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>H</given-names>
</name>
<name>
<surname>de Brito Alves</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Gut microbiota and probiotics intervention: a potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?</article-title>
<source/>Pharmacol Res
          <year>2018</year>
<volume>130</volume>
<fpage>152</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">29410236</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obermeier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Daneman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Development, maintenance and disruption of the blood-brain barrier</article-title>
<source/>Nat Med
          <year>2013</year>
<volume>19</volume>
<issue>12</issue>
<fpage>1584</fpage>
<pub-id pub-id-type="pmid">24309662</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochoa-Repáraz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mielcarz</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Ditrio</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Burroughs</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Begum-Haque</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dasgupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression</article-title>
<source/>J Immunol
          <year>2010</year>
<volume>185</volume>
<issue>7</issue>
<fpage>4101</fpage>
<lpage>4108</lpage>
<pub-id pub-id-type="pmid">20817872</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochoa-Repáraz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mielcarz</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Begum-Haque</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease</article-title>
<source/>Ann Neurol
          <year>2011</year>
<volume>69</volume>
<issue>2</issue>
<fpage>240</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">21387369</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohland</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Kish</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thiesen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hotte</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pankiv</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Madsen</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome</article-title>
<source/>Psychoneuroendocrinology
          <year>2013</year>
<volume>38</volume>
<issue>9</issue>
<fpage>1738</fpage>
<lpage>1747</lpage>
<pub-id pub-id-type="pmid">23566632</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozturk</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Turturice</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Finn</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>The potential for emerging microbiome-mediated therapeutics in asthma</article-title>
<source/>Curr Allergy Asthma Rep
          <year>2017</year>
<volume>17</volume>
<issue>9</issue>
<fpage>62</fpage>
<pub-id pub-id-type="pmid">28812256</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>44929</fpage>
<pub-id pub-id-type="pmid">28322317</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Interaction between gut microbiome and cardiovascular disease</article-title>
<source/>Life Sci
          <year>2018</year>
<volume>214</volume>
<fpage>153</fpage>
<pub-id pub-id-type="pmid">30385177</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piccio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis</article-title>
<source/>J Leukoc Biol
          <year>2008</year>
<volume>84</volume>
<issue>4</issue>
<fpage>940</fpage>
<lpage>948</lpage>
<pub-id pub-id-type="pmid">18678605</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pothoulakis</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Anti-inflammatory mechanisms of action of Saccharomyces boulardii</article-title>
<source/>Aliment Pharmacol Ther
          <year>2009</year>
<volume>30</volume>
<issue>8</issue>
<fpage>826</fpage>
<lpage>833</lpage>
<pub-id pub-id-type="pmid">19706150</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The anatomical and cellular basis of immune surveillance in the central nervous system</article-title>
<source/>Nat Rev Immunol
          <year>2012</year>
<volume>12</volume>
<issue>9</issue>
<fpage>623</fpage>
<pub-id pub-id-type="pmid">22903150</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodríguez-Nogales</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Algieri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Garrido-Mesa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vezza</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Utrilla</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Chueca</surname>
<given-names>N</given-names>
</name>
<name>
<surname>García</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rodríguez-Cabezas</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gálvez</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: impact on microRNAs expression and gut microbiota composition</article-title>
<source/>J Nutr Biochem
          <year>2018</year>
<volume>61</volume>
<fpage>129</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="pmid">30236870</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Doxey</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Neufeld</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>The skin microbiome of cohabiting couples</article-title>
<source/>MSystems
          <year>2017</year>
<volume>2</volume>
<issue>4</issue>
<fpage>e00043</fpage>
<lpage>e00017</lpage>
<pub-id pub-id-type="pmid">28761935</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Insights into the human gut microbiome and cardiovascular diseases</article-title>
<source/>J Pract Cardiovasc Sci
          <year>2018</year>
<volume>4</volume>
<issue>1</issue>
<fpage>10</fpage>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Schepper</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dagenais</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lemon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shinouskis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parameswaran</surname>
<given-names>N</given-names>
</name>
<name>
<surname>McCabe</surname>
<given-names>LR</given-names>
</name>
</person-group>
<article-title>Probiotics in gut-bone signaling</article-title>
<source/>Understanding the gut-bone signaling axis
          <year>2017</year>
<publisher-loc>Cham</publisher-loc>
<publisher-name>Springer</publisher-name>
<fpage>225</fpage>
<lpage>247</lpage>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segal</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Alekseyenko</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Clemente</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>KI</given-names>
</name>
<name>
<surname>Goldring</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Rom</surname>
<given-names>WN</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Weiden</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation</article-title>
<source/>Microbiome
          <year>2013</year>
<volume>1</volume>
<fpage>19</fpage>
<pub-id pub-id-type="pmid">24450871</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>CX</given-names>
</name>
<name>
<surname>Quan</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XY</given-names>
</name>
</person-group>
<article-title>Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation</article-title>
<source/>World J Gastroenterol
          <year>2018</year>
<volume>24</volume>
<issue>1</issue>
<fpage>5</fpage>
<pub-id pub-id-type="pmid">29358877</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silveira</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Rachid</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>da Cunha Sousa</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>dos Santos</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Gomes-Santos</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice</article-title>
<source/>Eur J Nutr
          <year>2017</year>
<volume>56</volume>
<issue>1</issue>
<fpage>179</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">26458966</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sivamaruthi</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Kesika</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Suganthy</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chaiyasut</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>A review on role of microbiome in obesity and Antiobesity properties of probiotic supplements</article-title>
<source/>BioMed Res Int
          <year>2019</year>
<volume>2019</volume>
<fpage>1</fpage>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soares</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Irritable bowel syndrome: a clinical review</article-title>
<source/>World J Gastroenterol
          <year>2014</year>
<volume>20</volume>
<issue>34</issue>
<fpage>12144</fpage>
<pub-id pub-id-type="pmid">25232249</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobol</surname>
<given-names>CV</given-names>
</name>
</person-group>
<article-title>How microbiome impact on the cardiovascular system</article-title>
<source/>J Clin Trial Cardiol
          <year>2014</year>
<volume>1</volume>
<fpage>1411</fpage>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swidsinski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Loening-Baucke</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lochs</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hale</surname>
<given-names>LP</given-names>
</name>
</person-group>
<article-title>Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice</article-title>
<source/>World J Gastroenterol
          <year>2005</year>
<volume>11</volume>
<issue>8</issue>
<fpage>1131</fpage>
<pub-id pub-id-type="pmid">15754393</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okuno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moriya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kohda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Honorat</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kumanogoh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kayama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sakoda</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<issue>11</issue>
<fpage>e27644</fpage>
<pub-id pub-id-type="pmid">22110705</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Hazen</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>The gut microbiome and its role in cardiovascular diseases</article-title>
<source/>Circulation
          <year>2017</year>
<volume>135</volume>
<issue>11</issue>
<fpage>1008</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="pmid">28289004</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarrah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>De Castilhos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Corich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Giacomini</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>In vitro probiotic potential and anti-cancer activity of newly isolated folate-producing Streptococcus thermophilus strains</article-title>
<source/>Front Microbiol
          <year>2018</year>
<volume>9</volume>
<fpage>2214</fpage>
<pub-id pub-id-type="pmid">30283428</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teitelbaum</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Gareau</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Jury</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Perdue</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress</article-title>
<source/>Am J Physiol Gastroint Liver Physiol
          <year>2008</year>
<volume>295</volume>
<issue>3</issue>
<fpage>G452</fpage>
<lpage>G459</lpage>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thaiss</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Zmora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Elinav</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The microbiome and innate immunity</article-title>
<source/>Nature
          <year>2016</year>
<volume>535</volume>
<issue>7610</issue>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">27383981</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<mixed-citation publication-type="other">Ticinesi A, Lauretani F, Tana C, Nouvenne A, Ridolo E, Meschi T (2019) Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis. Exerc Immunol Rev 25</mixed-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Tomayko</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pillsbury</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pray</surname>
<given-names>L</given-names>
</name>
</person-group>
<source/>The human microbiome, diet, and health: workshop summary
          <year>2013</year>
<publisher-loc>Washington, DC</publisher-loc>
<publisher-name>National Academies Press</publisher-name>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbough</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>“ Take your medicine”: nonadherence issues in patients with ulcerative colitis</article-title>
<source/>Gastroenterol Nurs
          <year>2007</year>
<volume>30</volume>
<issue>3</issue>
<fpage>212</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="pmid">17568260</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tursunov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yrysov</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sabirov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Alimova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Reyer</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hamajima</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Estimated costs for treatment and prophylaxis of newborn vitamin K deficiency bleeding in Tashkent, Uzbekistan</article-title>
<source/>Nagoya J Med Sci
          <year>2018</year>
<volume>80</volume>
<issue>1</issue>
<fpage>11</fpage>
<pub-id pub-id-type="pmid">29581610</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdes</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Role of the gut microbiota in nutrition and health</article-title>
<source/>BMJ
          <year>2018</year>
<volume>361</volume>
<fpage>k2179</fpage>
<pub-id pub-id-type="pmid">29899036</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandeputte</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vieira-Silva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sailer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Theis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Verbeke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Prebiotic inulin-type fructans induce specific changes in the human gut microbiota</article-title>
<source/>Gut
          <year>2017</year>
<volume>66</volume>
<issue>11</issue>
<fpage>1968</fpage>
<lpage>1974</lpage>
<pub-id pub-id-type="pmid">28213610</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>The role of microbiome in central nervous system disorders</article-title>
<source/>Brain Behav Immun
          <year>2014</year>
<volume>38</volume>
<fpage>1</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="pmid">24370461</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The human microbiota in health and disease</article-title>
<source/>Engineering
          <year>2017</year>
<volume>3</volume>
<issue>1</issue>
<fpage>71</fpage>
<lpage>82</lpage>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McNulty</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Rodionov</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Khoroshkin</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>NW</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Latreille</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kerstetter</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Terrapon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Henrissat</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Osterman</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides</article-title>
<source/>Science
          <year>2015</year>
<volume>350</volume>
<issue>6256</issue>
<fpage>5992</fpage>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yatera</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mukae</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The microbiome in the lower respiratory tract</article-title>
<source/>Respir Investig
          <year>2018</year>
<volume>56</volume>
<issue>6</issue>
<fpage>432</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="pmid">30392534</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Selective and suppressive effects of antibiotics on donor and recipient bacterial strains in gut microbiota determine transmission efficiency of bla NDM-1-bearing plasmids</article-title>
<source/>J Antimicrob Chemother
          <year>2019</year>
<volume>74</volume>
<issue>7</issue>
<fpage>1867</fpage>
<lpage>1875</lpage>
<pub-id pub-id-type="pmid">30989200</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yosef</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Manor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kiro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Qimron</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria</article-title>
<source/>Proc Natl Acad Sci
          <year>2015</year>
<volume>112</volume>
<issue>23</issue>
<fpage>7267</fpage>
<lpage>7272</lpage>
<pub-id pub-id-type="pmid">26060300</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshii</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hosomi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sawane</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kunisawa</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Metabolism of dietary and microbial vitamin B family in the regulation of host immunity</article-title>
<source/>Front Nutr
          <year>2019</year>
<volume>6</volume>
<fpage>48</fpage>
<pub-id pub-id-type="pmid">31058161</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>